As the hospitality industry is poised ready for the announcement of the new Michelin stars for Great Britain and Ireland ...

Despite the death of its golden goose, AbbVie expects to achieve high single-digit compound annual sales growth to the end of ...

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results ...

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the real estate services industry ...

Procter & Gamble has been treading water for the past six months, holding steady at $167.30. The stock also fell short of the ...

For now, her focus is on making the most of its existing portfolio, notably Keytruda – the world’s top-selling cancer drug – ...

Warnings of weak economic growth, resurgent inflation, and falling interest rates pose a toxic cocktail for Lloyds' share ...

WEC Energy boosts its dividend for the 22nd year, with strong growth prospects and a $28B investment plan. Find out why WEC ...

On the charts, EUR/USD appears to have deflated from its recent peaks near 1.0450. The pair should find some decent support ...

What It's All About In recent years, the conversation around renewable energy has gained significant momentum. Champions of ...

A UK growth stock has signed another contract with SpaceX. But does this mean it deserves a place in my Stocks and Shares ISA ...

Palantir's high valuation and market risks make it a risky investment, with a potential 60-70% downside from current price ...